Raymond James Trust’s Allergan Inc AGN Stock Holding History

Raymond James Trust’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6,505	Closed	-$1.38M	–	676
2014 Q4	$1.38M	Sell	6,505 -239	-4%	-$47.5K	0.15%	153
2014 Q3	$1.2M	Sell	6,744 -530	-7%	-$88K	0.14%	160
2014 Q2	$1.23M	Sell	7,274 -704	-9%	-$110K	0.14%	149
2014 Q1	$990K	Sell	7,978 -483	-6%	-$58.8K	0.12%	176
2013 Q4	$940K	Buy	8,461 +14	+0.2%	+$1.34K	0.12%	171
2013 Q3	$764K	Sell	8,447 -365	-4%	-$32.8K	0.12%	181
2013 Q2	$742K	Buy	+8,812	New	+$914K	0.12%	180

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Raymond James Trust's AGN Position: Q1 2015 in Review

Raymond James Trust sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 6,505 shares — an estimated $1.38M sold.

Raymond James Trust first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.38M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Raymond James Trust reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Raymond James Trust sold 6,505 Allergan Inc shares in Q1 2015, an estimated $1.38M.
Raymond James Trust first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Raymond James Trust's Allergan Inc position peaked at $1.38M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Raymond James Trust's 13F filing for Q1 2015, filed 22 Apr 2015.